Skip to main content
. 2013 Nov-Dec;27(6):482–489. doi: 10.2500/ajra.2013.27.3976

Figure 3.

Figure 3.

Meta-analysis of leukotriene antagonist (LTA) versus intranasal corticosteroid (INCS) treatments in chronic rhinosinusitis with nasal polyposis (CRSwNP). Forest plot of pooled analyses of symptom scores in randomized control trials (RCTs) of CRSwNP patients treated with montelukast versus intranasal steroids.